About: Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.22 (+1.44%)
ORMP NASDAQ Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc share price
Atividade de preço de ORMP
Último preço
$ 4,220
Variação (24h)
0,06 USD (1,44%)
Volume
79.98K
Volume (média 4 sem.)
-
Abertura
$ 4,16
Variação do dia
$ 4,16 - $ 4,29
Fechamento anterior
$ 4,16
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ORMP price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals